ARX aroa biosurgery limited

Annual Report CEO's Report

  1. 6,020 Posts.
    lightbulb Created with Sketch. 1928
    Finally, the Company is targeting completion of its
    expanded manufacturing facility by the end of FY22.
    Operating capacity from the expansion will come on-line
    in phases as necessary, based on demand requirements
    for AROA’s products. AROA anticipates that
    following completion, it will have sufficient aggregate
    manufacturing facilities to support approximately
    NZ$100 million in sales per annum
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
62.5¢
Change
0.015(2.46%)
Mkt cap ! $215.6M
Open High Low Value Volume
61.0¢ 63.0¢ 61.0¢ $314.7K 504.9K

Buyers (Bids)

No. Vol. Price($)
1 10700 60.5¢
 

Sellers (Offers)

Price($) Vol. No.
63.0¢ 191221 5
View Market Depth
Last trade - 16.10pm 12/08/2025 (20 minute delay) ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.